Hyperaldosteronemia in rabbits inhibits the cardiac sarcolemmal Na+-K+ pump

Circulation Research

Volumn 86, Issue 1, 2000, Pages 37-42

  Mihailidou, Anastasia S ^a   Bundgaard, Henning ^c   Mardini, Mahidi ^a,b   Hansen, Peter S ^a,b   Kjeldsen, Keld ^c   Rasmussen, Helge H ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Rigshospitalet   (Denmark)

Author keywords

Cardiac; Mineralocorticoid receptor; Ouabain binding; Sodium; Spironolactone

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; SODIUM; SPIRONOLACTONE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; HORMONAL REGULATION; HYPERALDOSTERONISM; MALE; MEMBRANE CURRENT; NONHUMAN; PRIORITY JOURNAL; RABBIT; SODIUM CELL LEVEL;

EID: 0033974101     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.1.37     Document Type: Article

References (36)

1. +)-ATPase in rat kidney. J Steroid Biochem. 1972;3:181-191.
2. Verrey F, Kraehenbuhl JP, Rossier BC. Aldosterone induces a rapid increase in the rate of Na, K-ATPase gene transcription in cultured kidney cells. Mol Endocrinol. 1989;3:1369-1376.
3. +-ATPase-dependent sodium efflux in cortical collecting tubule of rabbits under different aldosterone status. Biochim Biophys Acta. 1990;1022:126-128.
4. 1 isoform specific in the renal cortical collecting duct. J Biol Chem. 1993;268:23469-23476.
5. Wiener H, Nielsen JM, Klaerke DA, Jørrgensen PL. Aldosterone and thyroid hormone modulation of α1-, β1-mRNA, and Na, K-pump sites in rabbit distal colon epithelium: evidence for a novel mechanism of escape from the effect of hyperaldosteronemia. J Membr Biol. 1993;133: 203-211.
6. Pearce P, Funder JW. High affinity aldosterone binding sites (type I receptors) in rat heart. Clin Exp Pharmacol Physiol. 1987;14:859-866.
7. +-ATPase gene expression in adult and neonatal rat cardiocytes. J Biol Chem. 1991;266:12058-12066.
8. Robert V, Silvestre J-S, Charlemagne D, Sabri A, Trouve P, Wassef M, Swynghedauw B, Delcayre C. Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension. 1995;26:971-978.
9. 2+ exchanger in aldosterone/salt-induced hypertension in guinea pigs. Cardiovasc Res. 1998;38:451-462.
10. + pump activation during short-term exposure of cardiac myocytes to aldosterone. Am J Physiol. 1998;274:C175-C181.
11. + pump activity in mammalian cardiac myocytes. Am J Physiol. 1993;265:C1201-C1210.
12. 3H]ouabain binding. Biochem J. 1986;240:725-730.
13. 2+-dependent pNPPase: age-dependent changes. Basic Res Cordial. 1995;90:323-331.
14. Dørrup I, Skajaa K, Clausen T. A simple and rapid method for the determination of the concentrations of magnesium, sodium, potassium and sodium, potassium pumps in human skeletal muscle. Clin Sci. 1988; 74:241-248.
15. 3H-ouabain binding sites and the active Na-K transport in skeletal muscle. Nature. 1981;293:739-741.
16. Hegyvary C. Effect of aldosterone and methylprednisolone on cardiac NaK-ATPase. Experientia. 1977;33:1280-1281.
17. + pumps in rat skeletal muscle. J Endocrinol. 1997;152:49-57.
18. Jaunin P, Horisberger J-D, Richter K, Good PJ, Rossier BC, Geering K. Processing, intracellular transport and functional expression of endogenous and exogenous α-β3 Na, K-ATPase complexes in Xenopus oocytes. J Biol Chem. 1992;267:577-585.
19. +)-ATPase of rat skeletal muscle. J Biol Chem. 1991;266:427-433.
20. Thompson CB, McDonough AA. Skeletal muscle Na, K-ATPase α and β subunit protein levels respond to hypokalemic challenge with isoform and muscle type specificity. J Biol Chem. 1996;271:32653-32658.
21. + depletion and changes in thyroid status. Eur J Pharmacol. 1985;113:373-382.
22. DeFronzo RA, Bia M, Smith D. Clinical disorders of hyperkalemia. Annu Rev Med. 1982;33:521-554.
23. Shattock MJ, Matsuura H, Ward JPT. Sodium pump current measured in cardiac ventricular myocytes isolated from control and potassium depleted rabbits. Cardiovasc Res. 1994;28:1854-1862.
24. Doohan MM, Gray DF, Hool LC, Robinson BG, Rasmussen HH. Thyroid status and regulation of intracellular sodium in rabbit heart. Am J Physiol. 1997;272:H1589-H1597.
25. 1-mRNA and -protein levels at steady state. Am J Physiol. 1992;262:C484-C492.
26. Swan JW, Anker SD, Walton C, Godsland IF, Clark A, Leyva F, Stevenson JC, Coats AJS. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol. 1997;30:527-532.
27. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circulation. 1990; 67:1355-1364.
28. Young M, Head G, Funder J. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol. 1995;269: E657-E662.
29. +-concentration in isolated human myocardium. Circulation. 1997;96(suppl I):I-178. Abstract.
30. 2+ electrochemical gradients in cardiac muscle and their relationship to force development. J Gen Physiol. 1982;80:325-351.
31. Noble D. Ionic mechanisms determining the timing of ventricular repolarization: significance for cardiac arrhythmias. Ann N Y Acad Sci. 1992; 644:1-22.
32. +-ATPase to growth-related genes in cardiac myocytes. J Biol Chem. 1998;24:15249-15256.
33. Kent RL, Hoober K, Cooper G IV. Load responsiveness of protein synthesis in adult mammalian myocardium: role of cardiac deformation linked to sodium influx. Circ Res. 1989;64:74-85.
34. Huang L, Kometiani P, Xie Z. Differential regulation of Na/K-ATPase α-subunit isoform gene expressions in cardiac myocytes by ouabain and other hypertrophic stimuli. J Mol Cell Cardiol. 1997;29:3157-3167.
35. Ramires FJA, Mansur A, Coelho O, Maranhao M, Mady C, Ramires JAF. Spironolactone and ventricular arrhythmias in patients with heart failure. Circulation. 1998; 98(suppl I):I-300. Abstract.
36. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709-717.